Definitive Analysis
Financial Statements
Company Industry Sector
Periods / Units
Fundamentals
Margins Returns Growth Rates Metrics/Ratios
Valuations
Projections DCF DDM EPV Multiples Valuations
Miscellaneous
Indicators Charts WACC Beta Predictability
Analysis Mode
Full Access
See Pricing Start Trial

Chaoju Eye Care Holdings Limited (2219.HK)

Category: Company Financial Metrics Sector: Healthcare Industry: Medical - Care Facilities Live Price: $2.69

Price & Enterprise Value Ratios

AVG 3AVG 5TTM2024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-31
Price / Earnings
11.83x
24.26x
9.56x
9.56x
11.89x
14.05x
20.09x
65.70x
114.47x
219.77x
PEG Ratio
0.25x
0.49x
-0.65
-0.65
0.54
0.87
0.66
1.02
1.20
2.30
Price / Free Cash Flow
10.86x
18.26x
5.26x
5.26x
9.52x
17.79x
17.18x
41.57x
73.85x
-1,221.43x
Price / Book
1.04x
3.14x
0.81x
0.81x
1.15x
1.16x
1.54x
11.06x
16.60x
20.71x
Price / Tangible Book
1.20x
3.54x
0.95x
0.95x
1.37x
1.28x
1.61x
12.50x
19.94x
26.55x
Price / Sales
2.00x
3.90x
1.33x
1.33x
1.99x
2.67x
3.26x
10.27x
12.12x
13.45x
EV / EBITDA
5.53x
11.75x
3.88x
3.88x
5.66x
7.06x
7.13x
35.01x
45.33x
60.70x
EV / EBIT
7.43x
14.97x
5.27x
5.27x
8.11x
8.92x
9.04x
43.52x
66.74x
108.69x
EV / Revenue
1.55x
3.35x
0.93x
0.93x
1.80x
1.91x
2.18x
9.93x
12.12x
13.77x
EV / Free Cash Flow
8.34x
15.34x
3.67x
3.67x
8.60x
12.75x
11.48x
40.19x
73.90x
-1,250.87x

Financial Health & Risk Metrics

AVG 3AVG 5TTM2024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-31
Altman Z-Score
4.3057
4.2227
4.0278
4.0278
4.1965
4.6927
4.9811
3.2153
2.0994
1.2962
Piotroski F-Score (9pt)
5.3333
6.8000
4.0000
4.0000
8.0000
4.0000
9.0000
9.0000
6.0000
0.0000
Beneish M-Score
-4.5954
-4.5725
-4.6014
-4.6014
-4.5679
-4.6169
-4.6138
-4.4625
-4.4199
-4.1243
Degree of Fin. Leverage
1.0489
1.0536
1.0451
1.0451
1.0420
1.0595
1.0459
1.0757
1.2138
1.4355
Liabilities / Assets
0.1783
0.1969
0.1926
0.1926
0.1863
0.1560
0.1509
0.2989
0.4472
0.5814
Interest Coverage
21.9425
20.5634
23.1921
23.1921
24.8159
17.8194
22.7781
14.2114
5.6776
3.2961
Debt / Equity
0.0086
0.0076
0.0175
0.0175
0.0030
0.0053
0.0030
0.0091
0.1343
0.4170
Debt / Assets
0.0070
0.0059
0.0141
0.0141
0.0024
0.0044
0.0025
0.0061
0.0699
0.1596
Current Ratio
5.8300
5.7692
5.0341
5.0341
5.0466
7.4092
8.6302
2.7258
1.5251
1.1721
Quick Ratio
3.3816
3.3098
2.9106
2.9106
3.0834
4.1507
4.9030
1.5012
0.7037
0.6546

Cash Flow & Liquidity Metrics

AVG 3AVG 5TTM2024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-31
Cash to Revenue Ratio
0.62
0.73
0.56
0.56
0.34
0.95
1.26
0.52
0.34
0.25
Cash to Short-Term Debt Ratio
84.61
110.05
110.39
110.39
64.79
78.64
227.58
68.87
5.24
1.24
Cash to Long-Term Debt Ratio
214.22
—
23.27
23.27
-
-
1,753.33
609.51
9.88
3.50
Cash to Total Debt Ratio
3.57
4.13
3.58
3.58
2.31
4.82
7.04
2.90
0.98
0.43
Cash Ratio
2.50
3.05
2.30
2.30
1.35
3.86
5.67
2.08
0.89
0.38
Cash Conversion Cycle
26.77
28.13
13.22
13.22
31.49
35.59
26.78
33.57
24.80
127.78
Operating Cash Flow to Free Cash Flow Ratio
1.38
1.35
1.00
1.00
1.30
1.84
1.32
1.27
1.33
-12.98
Operating Cash Flow to Current Liabilities Ratio
1.08
1.12
1.04
1.04
1.09
1.12
1.12
1.25
0.58
0.22
Cash Return On Capital Employed
0.13
0.16
0.14
0.14
0.14
0.11
0.11
0.28
0.21
0.14
Cash Flow Return on Assets
0.12
0.14
0.12
0.12
0.13
0.10
0.10
0.23
0.16
0.08
Free Cash Flow Conversion Ratio
1.29
1.32
1.82
1.82
1.25
0.79
1.17
1.58
1.55
-0.18
Operating Cash Flow Yield
0.14
0.11
0.19
0.19
0.14
0.10
0.08
0.03
0.02
0.01
Free Cash Flow Yield
0.12
0.09
0.19
0.19
0.11
0.06
0.06
0.02
0.01
0.00
Unlevered Free Cash Flow Yield
0.16
0.12
0.27
0.27
0.12
0.08
0.09
0.02
0.01
0.00
Levered Free Cash Flow Yield
0.12
0.09
0.19
0.19
0.11
0.06
0.06
0.02
0.01
0.00

Capital & Working Capital Metrics

AVG 3AVG 5TTM2024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-31
Total Capital Turnover
0.49
0.56
0.55
0.55
0.53
0.40
0.44
0.90
0.93
0.82
Total Capital to Net Income Efficiency
0.08
0.09
0.08
0.08
0.09
0.08
0.07
0.14
0.10
0.05
Total Equity to Total Capital Ratio
0.92
0.90
0.91
0.91
0.92
0.92
0.92
0.84
0.68
0.53
Working Capital Turnover
0.88
1.11
1.03
1.03
0.99
0.63
0.59
2.32
5.03
9.00
Working Capital to Total Assets
0.51
0.50
0.48
0.48
0.47
0.58
0.68
0.31
0.14
0.07
Operating Cash Flow Working Capital Ratio
0.23
0.32
0.26
0.26
0.27
0.17
0.15
0.73
1.10
1.29
Working Capital Days
434.65
416.14
355.45
355.45
369.64
578.87
619.17
157.55
72.52
40.55
Capital Employed Turnover
0.49
0.56
0.55
0.55
0.53
0.40
0.44
0.89
0.98
0.95
Net Working Capital to Capital Employed Ratio
0.57
0.57
0.54
0.54
0.54
0.63
0.74
0.39
0.19
0.11
Equity to Capital Employed Ratio
0.91
0.90
0.91
0.91
0.91
0.92
0.92
0.83
0.71
0.62
Invested Capital Turnover
0.49
0.56
0.55
0.55
0.53
0.40
0.44
0.90
0.93
0.82
Invested Capital to Assets Ratio
0.89
0.88
0.88
0.88
0.88
0.91
0.91
0.81
0.76
0.72
Equity to Invested Capital Ratio
0.92
0.90
0.91
0.91
0.92
0.92
0.92
0.84
0.68
0.53

Debt Metrics & Leverage Ratios

AVG 3AVG 5TTM2024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-31
Cash to Short Term Debt Ratio
84.61
110.05
110.39
110.39
64.79
78.64
227.58
68.87
5.24
1.24
Operating Cash Flow to Short Term Debt Ratio
41.65
42.31
50.10
50.10
52.09
22.76
45.15
41.46
3.40
0.72
Long Term Debt to Total Assets
0.00
0.00
0.01
0.01
0.00
0.00
0.00
0.00
0.02
0.04
Short Term Debt to Current Assets Ratio
0.00
0.00
0.00
0.00
0.00
0.01
0.00
0.01
0.11
0.26
Short Term Debt to Current Liabilities Ratio
0.03
0.03
0.02
0.02
0.02
0.05
0.02
0.03
0.17
0.31
Total Debt to Total Assets Ratio
0.07
0.08
0.08
0.08
0.07
0.07
0.07
0.13
0.24
0.34
Total Debt to Shareholders Equity Ratio
0.09
0.11
0.09
0.09
0.09
0.09
0.08
0.19
0.47
0.88
Total Debt to EBITDA Ratio
0.61
0.61
0.65
0.65
0.46
0.73
0.59
0.63
1.28
2.52
Total Debt to Free Cash Flow Ratio
0.88
0.86
0.62
0.62
0.70
1.32
0.94
0.73
2.09
-52.02
Total Debt to Total Capital Ratio
0.08
0.10
0.09
0.09
0.08
0.08
0.08
0.16
0.32
0.47
Total Debt to Working Capital Ratio
0.14
0.19
0.16
0.16
0.14
0.12
0.11
0.42
1.73
5.15
Total Debt to Capital Employed Ratio
0.08
0.10
0.09
0.09
0.08
0.08
0.08
0.16
0.33
0.54
Total Debt to Invested Capital Ratio
0.08
0.10
0.09
0.09
0.08
0.08
0.08
0.16
0.32
0.47

Management & Efficiency Metrics

AVG 3AVG 5TTM2024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-31
Equity to Assets
81.53%
79.27%
80.40%
80.40%
80.75%
83.46%
84.03%
67.70%
52.02%
38.27%
Inventories to Assets
1.69%
1.99%
1.40%
1.40%
1.75%
1.92%
1.39%
3.49%
3.60%
4.34%
Inventory Turnover
14.98
14.48
19.70
19.70
14.64
10.60
15.73
11.71
12.11
8.33
Inventory to Revenue
3.96%
4.04%
2.87%
2.87%
3.73%
5.29%
3.50%
4.78%
5.05%
7.36%
Asset Turnover
0.44
0.49
0.49
0.49
0.47
0.36
0.40
0.73
0.71
0.59
Days Inventory
25.97
26.46
18.53
18.53
24.93
34.45
23.20
31.18
30.14
43.83
Days Sales Outstanding
27.66
29.13
19.33
19.33
33.56
30.07
28.05
34.63
36.90
142.94
Days Payable
26.86
27.46
24.64
24.64
27.00
28.94
24.46
32.24
42.25
58.99
Cost of Goods to Revenue
55.75%
55.66%
56.51%
56.51%
54.65%
56.09%
55.03%
56.00%
61.09%
61.28%
Capex to Revenue
7.85%
7.24%
4.59%
4.59%
6.32%
12.64%
6.03%
6.62%
5.41%
15.40%
Capex to Operating Income
37.88%
33.55%
26.09%
26.09%
28.54%
59.02%
25.07%
29.03%
29.76%
121.51%
Capex to Operating Cash Flow
29.06%
26.49%
18.19%
18.19%
23.23%
45.76%
24.14%
21.14%
24.78%
107.70%
Intangibles to Assets
10.84%
8.72%
12.19%
12.19%
12.76%
7.58%
3.27%
7.78%
8.71%
8.42%
Scaled Net Operating Assets
0.56
0.47
0.54
0.54
0.66
0.50
0.35
0.32
0.31
0.27
Shares Buyback Ratio
3.66%
0.36%
-0.77%
-0.77%
-1.37%
13.12%
-9.16%
0.00%
0.00%
-
Buyback Yield
0.32%
0.19%
0.13%
0.13%
0.00%
0.82%
0.00%
0.00%
0.00%
0.00%
Sloan Ratio
-4.53%
-5.71%
-5.53%
-5.53%
-4.91%
-3.15%
-3.50%
-11.44%
-8.00%
-4.82%